Lido Advisors LLC Purchases 31,354 Shares of AptarGroup, Inc. $ATR

Lido Advisors LLC boosted its holdings in AptarGroup, Inc. (NYSE:ATR – Free Report) by 586.9% in the third quarter, HoldingsChannel reports. The institutional investor owned 36,696 shares of the industrial products company’s stock after purchasing an additional 31,354 shares during the quarter. Lido Advisors LLC’s holdings in AptarGroup were worth $4,446,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Geneos Wealth Management Inc. lifted its stake in AptarGroup by 214.1% in the 1st quarter. Geneos Wealth Management Inc. now owns 201 shares of the industrial products company’s stock worth $25,000 after purchasing an additional 137 shares in the last quarter. Silvant Capital Management LLC purchased a new stake in AptarGroup in the 2nd quarter valued at about $30,000. Parkside Financial Bank & Trust increased its stake in shares of AptarGroup by 41.9% during the second quarter. Parkside Financial Bank & Trust now owns 298 shares of the industrial products company’s stock valued at $37,000 after buying an additional 88 shares during the period. Global Retirement Partners LLC bought a new position in AptarGroup in the second quarter worth approximately $46,000. Finally, Root Financial Partners LLC purchased a new stake in shares of AptarGroup during the 3rd quarter worth $46,000. Institutional investors own 88.52% of the company’s stock.

More AptarGroup News

These are some of the ATR news items that stood out recently:

  • Positive Sentiment: Zacks Research lifted its FY2026 EPS estimate to $5.53 from $5.46, FY2027 to $5.91 from $5.90, and FY2028 to $6.65 from $6.53. It also raised estimates for several upcoming quarters, including Q4 2026, Q1–Q3 2027 and Q1–Q3 2028. The broad upward revisions could support investor optimism about AptarGroup’s earnings outlook.
  • Negative Sentiment: Zacks Research reduced its Q4 2027 EPS forecast to $1.46 from $1.49, a limited offset to the generally higher estimates.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Weiss Ratings reiterated a “hold (c)” rating on shares of AptarGroup in a report on Monday, September 21st. Deutsche Bank initiated coverage on shares of AptarGroup in a research note on Wednesday, October 7th. They set a “buy” rating and a $150.00 price objective on the stock. Bank of America restated a “buy” rating on shares of AptarGroup in a research report on Monday, November 2nd. Wells Fargo & Company lifted their price target on shares of AptarGroup from $145.00 to $155.00 and gave the company an “overweight” rating in a research note on Monday, August 3rd. Finally, UBS Group began coverage on AptarGroup in a research note on Friday, October 9th. They set a “neutral” rating and a $135.00 price objective for the company. Five research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $164.14.

Check Out Our Latest Stock Report on AptarGroup

Insiders Place Their Bets

In related news, CEO Gael Touya sold 3,740 shares of the company’s stock in a transaction that occurred on Thursday, August 27th. The shares were sold at an average price of $133.76, for a total transaction of $500,262.40. Following the sale, the chief executive officer directly owned 29,102 shares of the company’s stock, valued at $3,892,683.52. This represents a 11.39% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Shiela Vinczeller sold 765 shares of the company’s stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $130.37, for a total value of $99,733.05. Following the sale, the insider owned 26,313 shares in the company, valued at approximately $3,430,425.81. This trade represents a 2.83% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.73% of the company’s stock.

AptarGroup Price Performance

Shares of ATR stock opened at $143.12 on Monday. AptarGroup, Inc. has a 12 month low of $110.95 and a 12 month high of $148.63. The company has a market capitalization of $9.07 billion, a PE ratio of 34.74, a price-to-earnings-growth ratio of 4.17 and a beta of 0.32. The firm’s 50-day moving average is $128.06 and its two-hundred day moving average is $127.94. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.50 and a quick ratio of 1.03.

AptarGroup (NYSE:ATR – Get Free Report) last posted its earnings results on Thursday, October 29th. The industrial products company reported $1.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.47 by $0.05. The company had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $980.76 million. AptarGroup had a return on equity of 13.11% and a net margin of 6.69%. The firm’s quarterly revenue was up 6.0% compared to the same quarter last year. During the same quarter last year, the firm earned $1.62 earnings per share. Analysts predict that AptarGroup, Inc. will post 5.56 earnings per share for the current year.

AptarGroup Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 3rd. Investors of record on Thursday, November 12th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend is Thursday, November 12th. This is an increase from AptarGroup’s previous quarterly dividend of $0.48. AptarGroup’s dividend payout ratio is 48.54%.

AptarGroup Company Profile

(Free Report)

AptarGroup is a global provider of dispensing, packaging and drug-delivery solutions. Its products include pumps, aerosol valves, sprayers, closures and other components used to package and dispense products. The company serves customers in the pharmaceutical, beauty, personal care, food and beverage markets. Its pharmaceutical offerings include systems and components for delivering medicines through nasal, inhaled, ophthalmic and injectable applications, while its packaging solutions help consumer brands dispense and protect products.

Recommended Stories

Want to see what other hedge funds are holding ATR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AptarGroup, Inc. (NYSE:ATR – Free Report).

Institutional Ownership by Quarter for AptarGroup (NYSE:ATR)

Receive News & Ratings for AptarGroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup and related companies with MarketBeat.com's FREE daily email newsletter.